2025 MCM | Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer

2025 MCM | Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
Jun 24, 2025
Last Review
Jun 24, 2025
Expires
Jun 24, 2026

Target Audience

Physicians

Nurses

Pharmacists

Physician Associates

Faculty & Disclosure

Faculty

Mariana Chavez MacGregor, MD, MSc, FASCO

Disclosure

Mariana Chavez MacGregor, MD, MSc, FASCO

Accreditation

NA